Salman Karim
Preston, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Liraglutide in mild to moderate Alzheimer's disease: a phase 2b clinical trial.
Journal: Nature medicine
Published: June 17, 2025
Prevalence of dementia and mild cognitive impairment among the older prisoner population in England and Wales: a cross-sectional study.
Journal: BMJ open
Published: April 09, 2025
Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer's subjects?
Journal: Alzheimer's research & therapy
Published: November 14, 2020
Diagnostic Biomarkers for Alzheimer's Disease Using Non-Invasive Specimens.
Journal: Journal of clinical medicine
Published: May 07, 2020
Computerised cognitive training for 12 or more weeks for maintaining cognitive function in cognitively healthy people in late life.
Journal: The Cochrane database of systematic reviews
Published: February 28, 2020
A roadmap to develop dementia research capacity and capability in Pakistan: A model for low- and middle-income countries.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: January 11, 2020
Computerised cognitive training for preventing dementia in people with mild cognitive impairment.
Journal: The Cochrane database of systematic reviews
Published: March 14, 2019
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife.
Journal: The Cochrane database of systematic reviews
Published: March 14, 2019
Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life.
Journal: The Cochrane database of systematic reviews
Published: March 14, 2019
Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer's disease: study protocol for a randomised controlled trial (ELAD study).
Journal: Trials
Published: March 23, 2018
Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.
Journal: The lancet. Psychiatry
Published: November 03, 2016
Last Updated: 09/26/2026